371 related articles for article (PubMed ID: 30578352)
1. Tuberculosis and impaired IL-23-dependent IFN-γ immunity in humans homozygous for a common
Boisson-Dupuis S; Ramirez-Alejo N; Li Z; Patin E; Rao G; Kerner G; Lim CK; Krementsov DN; Hernandez N; Ma CS; Zhang Q; Markle J; Martinez-Barricarte R; Payne K; Fisch R; Deswarte C; Halpern J; Bouaziz M; Mulwa J; Sivanesan D; Lazarov T; Naves R; Garcia P; Itan Y; Boisson B; Checchi A; Jabot-Hanin F; Cobat A; Guennoun A; Jackson CC; Pekcan S; Caliskaner Z; Inostroza J; Costa-Carvalho BT; de Albuquerque JAT; Garcia-Ortiz H; Orozco L; Ozcelik T; Abid A; Rhorfi IA; Souhi H; Amrani HN; Zegmout A; Geissmann F; Michnick SW; Muller-Fleckenstein I; Fleckenstein B; Puel A; Ciancanelli MJ; Marr N; Abolhassani H; Balcells ME; Condino-Neto A; Strickler A; Abarca K; Teuscher C; Ochs HD; Reisli I; Sayar EH; El-Baghdadi J; Bustamante J; Hammarström L; Tangye SG; Pellegrini S; Quintana-Murci L; Abel L; Casanova JL
Sci Immunol; 2018 Dec; 3(30):. PubMed ID: 30578352
[TBL] [Abstract][Full Text] [Related]
2. The monogenic basis of human tuberculosis.
Boisson-Dupuis S
Hum Genet; 2020 Jun; 139(6-7):1001-1009. PubMed ID: 32055999
[TBL] [Abstract][Full Text] [Related]
3. Homozygosity for
Kerner G; Ramirez-Alejo N; Seeleuthner Y; Yang R; Ogishi M; Cobat A; Patin E; Quintana-Murci L; Boisson-Dupuis S; Casanova JL; Abel L
Proc Natl Acad Sci U S A; 2019 May; 116(21):10430-10434. PubMed ID: 31068474
[TBL] [Abstract][Full Text] [Related]
4. Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency.
Ogishi M; Arias AA; Yang R; Han JE; Zhang P; Rinchai D; Halpern J; Mulwa J; Keating N; Chrabieh M; Lainé C; Seeleuthner Y; Ramírez-Alejo N; Nekooie-Marnany N; Guennoun A; Muller-Fleckenstein I; Fleckenstein B; Kilic SS; Minegishi Y; Ehl S; Kaiser-Labusch P; Kendir-Demirkol Y; Rozenberg F; Errami A; Zhang SY; Zhang Q; Bohlen J; Philippot Q; Puel A; Jouanguy E; Pourmoghaddas Z; Bakhtiar S; Willasch AM; Horneff G; Llanora G; Shek LP; Chai LYA; Tay SH; Rahimi HH; Mahdaviani SA; Nepesov S; Bousfiha AA; Erdeniz EH; Karbuz A; Marr N; Navarrete C; Adeli M; Hammarstrom L; Abolhassani H; Parvaneh N; Al Muhsen S; Alosaimi MF; Alsohime F; Nourizadeh M; Moin M; Arnaout R; Alshareef S; El-Baghdadi J; Genel F; Sherkat R; Kiykim A; Yücel E; Keles S; Bustamante J; Abel L; Casanova JL; Boisson-Dupuis S
J Exp Med; 2022 Oct; 219(10):. PubMed ID: 36094518
[TBL] [Abstract][Full Text] [Related]
5. The
Gorman JA; Hundhausen C; Kinsman M; Arkatkar T; Allenspach EJ; Clough C; West SE; Thomas K; Eken A; Khim S; Hale M; Oukka M; Jackson SW; Cerosaletti K; Buckner JH; Rawlings DJ
Front Immunol; 2019; 10():44. PubMed ID: 30740104
[TBL] [Abstract][Full Text] [Related]
6. Two rare disease-associated Tyk2 variants are catalytically impaired but signaling competent.
Li Z; Gakovic M; Ragimbeau J; Eloranta ML; Rönnblom L; Michel F; Pellegrini S
J Immunol; 2013 Mar; 190(5):2335-44. PubMed ID: 23359498
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of TYK2 and JAK1 ameliorates imiquimod-induced psoriasis-like dermatitis by inhibiting IL-22 and the IL-23/IL-17 axis.
Works MG; Yin F; Yin CC; Yiu Y; Shew K; Tran TT; Dunlap N; Lam J; Mitchell T; Reader J; Stein PL; D'Andrea A
J Immunol; 2014 Oct; 193(7):3278-87. PubMed ID: 25156366
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine kinase 2 is not limiting human antiviral type III interferon responses.
Fuchs S; Kaiser-Labusch P; Bank J; Ammann S; Kolb-Kokocinski A; Edelbusch C; Omran H; Ehl S
Eur J Immunol; 2016 Nov; 46(11):2639-2649. PubMed ID: 27615517
[TBL] [Abstract][Full Text] [Related]
9. Identification of rare coding variants in
Motegi T; Kochi Y; Matsuda K; Kubo M; Yamamoto K; Momozawa Y
Ann Rheum Dis; 2019 Aug; 78(8):1062-1069. PubMed ID: 31118190
[TBL] [Abstract][Full Text] [Related]
10. A restricted role for TYK2 catalytic activity in human cytokine responses revealed by novel TYK2-selective inhibitors.
Sohn SJ; Barrett K; Van Abbema A; Chang C; Kohli PB; Kanda H; Smith J; Lai Y; Zhou A; Zhang B; Yang W; Williams K; Macleod C; Hurley CA; Kulagowski JJ; Lewin-Koh N; Dengler HS; Johnson AR; Ghilardi N; Zak M; Liang J; Blair WS; Magnuson S; Wu LC
J Immunol; 2013 Sep; 191(5):2205-16. PubMed ID: 23894201
[TBL] [Abstract][Full Text] [Related]
11. Human TYK2 deficiency: Mycobacterial and viral infections without hyper-IgE syndrome.
Kreins AY; Ciancanelli MJ; Okada S; Kong XF; Ramírez-Alejo N; Kilic SS; El Baghdadi J; Nonoyama S; Mahdaviani SA; Ailal F; Bousfiha A; Mansouri D; Nievas E; Ma CS; Rao G; Bernasconi A; Sun Kuehn H; Niemela J; Stoddard J; Deveau P; Cobat A; El Azbaoui S; Sabri A; Lim CK; Sundin M; Avery DT; Halwani R; Grant AV; Boisson B; Bogunovic D; Itan Y; Moncada-Velez M; Martinez-Barricarte R; Migaud M; Deswarte C; Alsina L; Kotlarz D; Klein C; Muller-Fleckenstein I; Fleckenstein B; Cormier-Daire V; Rose-John S; Picard C; Hammarstrom L; Puel A; Al-Muhsen S; Abel L; Chaussabel D; Rosenzweig SD; Minegishi Y; Tangye SG; Bustamante J; Casanova JL; Boisson-Dupuis S
J Exp Med; 2015 Sep; 212(10):1641-62. PubMed ID: 26304966
[TBL] [Abstract][Full Text] [Related]
12. Tyk2 negatively regulates adaptive Th1 immunity by mediating IL-10 signaling and promoting IFN-gamma-dependent IL-10 reactivation.
Shaw MH; Freeman GJ; Scott MF; Fox BA; Bzik DJ; Belkaid Y; Yap GS
J Immunol; 2006 Jun; 176(12):7263-71. PubMed ID: 16751369
[TBL] [Abstract][Full Text] [Related]
13. Expression of Tyk2 in dendritic cells is required for IL-12, IL-23, and IFN-gamma production and the induction of Th1 cell differentiation.
Tokumasa N; Suto A; Kagami S; Furuta S; Hirose K; Watanabe N; Saito Y; Shimoda K; Iwamoto I; Nakajima H
Blood; 2007 Jul; 110(2):553-60. PubMed ID: 17395783
[TBL] [Abstract][Full Text] [Related]
14. Tyk2-dependent bystander activation of conventional and nonconventional Th1 cell subsets contributes to innate host defense against Listeria monocytogenes infection.
Hashiguchi T; Oyamada A; Sakuraba K; Shimoda K; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H
J Immunol; 2014 May; 192(10):4739-47. PubMed ID: 24729620
[TBL] [Abstract][Full Text] [Related]
15. Differential requirements for JAK2 and TYK2 in T cell proliferation and IFN-gamma production induced by IL-12 alone or together with IL-18.
Sugimoto N; Nakahira M; Ahn HJ; Micallef M; Hamaoka T; Kurimoto M; Fujiwara H
Eur J Immunol; 2003 Jan; 33(1):243-51. PubMed ID: 12594853
[TBL] [Abstract][Full Text] [Related]
16. Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway.
López-Isac E; Campillo-Davo D; Bossini-Castillo L; Guerra SG; Assassi S; Simeón CP; Carreira P; Ortego-Centeno N; García de la Peña P; ; Beretta L; Santaniello A; Bellocchi C; Lunardi C; Moroncini G; Gabrielli A; Riemekasten G; Witte T; Hunzelmann N; Kreuter A; Distler JH; Voskuyl AE; de Vries-Bouwstra J; Herrick A; Worthington J; Denton CP; Fonseca C; Radstake TR; Mayes MD; Martín J
Ann Rheum Dis; 2016 Aug; 75(8):1521-6. PubMed ID: 26338038
[TBL] [Abstract][Full Text] [Related]
17. Two common disease-associated TYK2 variants impact exon splicing and TYK2 dosage.
Li Z; Rotival M; Patin E; Michel F; Pellegrini S
PLoS One; 2020; 15(1):e0225289. PubMed ID: 31961910
[TBL] [Abstract][Full Text] [Related]
18. Human ancient DNA analyses reveal the high burden of tuberculosis in Europeans over the last 2,000 years.
Kerner G; Laval G; Patin E; Boisson-Dupuis S; Abel L; Casanova JL; Quintana-Murci L
Am J Hum Genet; 2021 Mar; 108(3):517-524. PubMed ID: 33667394
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive assessment of the association between genes on JAK-STAT pathway (IFIH1, TYK2, IL-10) and systemic lupus erythematosus: a meta-analysis.
Yin Q; Wu LC; Zheng L; Han MY; Hu LY; Zhao PP; Bai WY; Zhu XW; Xia JW; Wang XB; Zhang XW; Zheng HF
Arch Dermatol Res; 2018 Nov; 310(9):711-728. PubMed ID: 30171347
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Suppresses Type I Interferon Signaling To Promote EBV Reactivation.
Liu X; Sadaoka T; Krogmann T; Cohen JI
J Virol; 2020 May; 94(11):. PubMed ID: 32213613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
